Previous 10 | Next 10 |
home / stock / onc:cc / onc:cc news
2023-09-22 10:15:25 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal , optimism in the b...
2023-09-20 11:40:13 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their &...
2023-09-19 12:25:41 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 19, 2023 – USA News Group – A new cancer-focused venture capital firm is making headlines, having debuted with $200 million in funding f...
Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference PR Newswire SAN DIEGO and CALGARY, AB , Sept. 19, 2023 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherap...
2023-09-13 09:00:30 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food and Drug Administr...
Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire SAN DIEGO and CALGARY, AB , Sept. 6, 2023 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today...
2023-08-24 20:00:00 ET Oncolytics Biotech is now ranked among the top 10 undervalued small cap growth stocks on the Toronto Stock Exchange (TSX). A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (tru...
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights Canada NewsWire Phase 2 data from randomized BRACELET-1 trial in HR+/HER2- metastatic breast cancer showed a near tripling of confirmed ORR, >50% improvement in PFS, and 7...
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference PR Newswire SAN DIEGO and CALGARY, AB , Aug. 4, 2023 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced t...
2023-07-12 09:00:00 ET The S&P/TSX Composite Index moved up 56 points on Tuesday, July 11. Meanwhile, the S&P/TSX Capped Health Care Index was up roughly half a percentage point after the same trading session. Today, I want to zero in on the fastest-growing sub-sector in the...
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONC:CC Stock Symbol:
TSXC Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program PR Newswire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report overall...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence PR Newswire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast cancer...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...